Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/dm/volume-2016/7862469/figures/7862469.fig.004a.svgz" name="7862469.fig.004a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Begg’s funnel plot with pseudo 95% confidence limits</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/dm/volume-2016/7862469/figures/7862469.fig.004b.svgz" name="7862469.fig.004b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Egger’s publication bias plot</td></tr></table>

<div>(a) Begg’s test. (b) Egger’s test.</div>

Disease Markers

fig4

Figure 4

Figure 4: Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis 